Toronto Dominion Bank Has $104.63 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Toronto Dominion Bank lowered its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 15.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 376,352 shares of the conglomerate's stock after selling 69,881 shares during the period. Toronto Dominion Bank owned about 0.05% of Danaher worth $104,633,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of DHR. Diversified Trust Co lifted its stake in shares of Danaher by 75.4% in the 2nd quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate's stock valued at $1,090,000 after purchasing an additional 1,874 shares during the last quarter. Great Valley Advisor Group Inc. boosted its position in shares of Danaher by 11.4% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 1,585 shares of the conglomerate's stock valued at $396,000 after acquiring an additional 162 shares in the last quarter. ORG Partners LLC boosted its position in shares of Danaher by 7,633.3% during the 2nd quarter. ORG Partners LLC now owns 464 shares of the conglomerate's stock valued at $114,000 after acquiring an additional 458 shares in the last quarter. GPS Wealth Strategies Group LLC boosted its position in shares of Danaher by 26.1% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 590 shares of the conglomerate's stock valued at $147,000 after acquiring an additional 122 shares in the last quarter. Finally, PGGM Investments boosted its position in shares of Danaher by 805.1% during the 2nd quarter. PGGM Investments now owns 16,636 shares of the conglomerate's stock valued at $4,157,000 after acquiring an additional 14,798 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Up 0.9 %

DHR traded up $2.16 during trading hours on Wednesday, hitting $236.50. 1,440,447 shares of the company's stock were exchanged, compared to its average volume of 2,773,032. Danaher Co. has a 1-year low of $218.48 and a 1-year high of $281.70. The stock's 50-day moving average is $249.11 and its two-hundred day moving average is $257.94. The stock has a market cap of $170.82 billion, a price-to-earnings ratio of 45.09, a PEG ratio of 4.23 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company's revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter last year, the company posted $2.02 earnings per share. Sell-side analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.46%. Danaher's dividend payout ratio is currently 20.61%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on DHR shares. Wells Fargo & Company started coverage on shares of Danaher in a research report on Tuesday, August 27th. They issued an "equal weight" rating and a $280.00 price target on the stock. Barclays reduced their price target on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating on the stock in a research report on Wednesday, October 23rd. Raymond James reduced their target price on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI upped their target price on shares of Danaher from $275.00 to $278.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 1st. Finally, Wolfe Research upgraded shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 target price on the stock in a research report on Thursday, October 31st. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.